Missouri · 2026 Regular Session · Bill
SB 1724: Makes xylazine a Schedule III controlled substance
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SB 1724 is a bill introduced in the Missouri Senate on February 25, 2026. According to its official title, it concerns: Makes xylazine a Schedule III controlled substance. Primary sponsor: Justin Brown (Republican). Most recent recorded action (May 7, 2026): Second Read and Referred S Judiciary and Civil and Criminal Jurisprudence Committee.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
SB 1724 - This act makes xylazine a Schedule III controlled substance, except for certain uses described in the act, including manufacturing a drug for an animal or administering the drug to an animal. This act is substantially similar to HB 1881 (2026). SARAH HASKINS
Sponsors
Sponsors by party (alphabetical): Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Justin Brown | Primary sponsor | Republican | Senate | 16 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Second Read and Referred S Judiciary and Civil and Criminal Jurisprudence Committee
- S First Read